Abstract
A simple, rapid, and reproducible reversed-phase LC method with UV detection at 215 nm has been developed for analysis of SP-8203 in rat samples. A C18 column was used with 3,000:1,050 (v/v) 0.01 m K2HPO4 buffer (pH 3)–acetonitrile as mobile phase at a flow rate of 1.7 mL min−1 at 50 °C. Samples were extracted with dichloromethane containing ondansetron (internal standard). Detection limits for SP-8203 in plasma, urine, and gastrointestinal tract samples were 0.05, 0.5, and 10 μg mL−1, respectively. The method was suitable for pharmacokinetic study of SP-8203 in rats after intravenous administration.
References
Aversa A, Bruzziches R, Pili M, Spera G (2006) Curr Pharm Res 12:3467–3484
Lincoln TM (2004) Mol Pharmacol 66:776–784
Broderick GA (2003) Rev Urol 5:S9–S20
Lee J, Yoo HH, Rhim KJ, Sohn D-R, Kim D-H (2007) Rapid Commun Mass Spectrom 21:1139–1149
Choi YH, Kim SG, Lee MG (2006) J Pharm Sci 95:2543–2552
Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn. Marcel Dekker, New York
Chiou WL (1978) J Pharmacokinet Biopharm 6:539–546
Acknowledgments
This study was supported by the contract ‘Pharmacokinetics of SP-8203’ from Shin Poong Pharmaceutical Company, Ltd, Ansan, South Korea.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choi, Y.H., Suh, J.H., Lee, J.H. et al. LC−UV Analysis of N-{3-(2,4-Dioxo-1,4-dihydro-2H-quinazolin-3-yl)propyl}-N-[4-{3-(2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)propyl-amino}butyl]acetamide (SP-8203) in Rat Plasma, Urine, and Gastrointestinal Tract Samples. Chroma 70, 1435–1439 (2009). https://doi.org/10.1365/s10337-009-1327-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-009-1327-1